Mizuho Securities Sticks to Its Hold Rating for Qorvo (QRVO)
Mizuho Securities analyst Vijay Rakesh maintained a Hold rating on Qorvo (QRVO – Research Report) today and set a price target of $85.00. The ...
Qorvo Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a two-day winning streak.
Globus Medical to buy Nevro in $250M all-cash deal
Globus Medical (GMED) has agreed to buy Nevro (NVRO) through an all-cash deal valued at around $250M. Read more here.